NO880760D0 - PHARMACEUTICAL PARTICULARS IMPROVEMENT. - Google Patents

PHARMACEUTICAL PARTICULARS IMPROVEMENT.

Info

Publication number
NO880760D0
NO880760D0 NO880760A NO880760A NO880760D0 NO 880760 D0 NO880760 D0 NO 880760D0 NO 880760 A NO880760 A NO 880760A NO 880760 A NO880760 A NO 880760A NO 880760 D0 NO880760 D0 NO 880760D0
Authority
NO
Norway
Prior art keywords
active ingredient
improvement
particulars
pharmaceutical
pellets
Prior art date
Application number
NO880760A
Other languages
Norwegian (no)
Other versions
NO880760L (en
Inventor
Christian Fechner
Michael Huempel
Fred Windt-Hanke
Johannes Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6304389&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO880760(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO880760D0 publication Critical patent/NO880760D0/en
Publication of NO880760L publication Critical patent/NO880760L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Medicaments with delayed release of the active ingredient, containing a poorly water-insoluble active ingredient and additives, characterized in that the active ingredient is distributed in or on pellets in a microcrystalline or molecularly dispersed form, and that said pellets are coated with a permeable membrane which delays the release of the active ingredient.
NO880760A 1986-07-02 1988-02-22 PHARMACEUTICAL PARTICULARS IMPROVEMENT. NO880760L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863622487 DE3622487A1 (en) 1986-07-02 1986-07-02 MEDICINAL PRODUCTS WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES
PCT/DE1987/000295 WO1988000046A1 (en) 1986-07-02 1987-06-29 Medicaments with delayed release of active ingredient

Publications (2)

Publication Number Publication Date
NO880760D0 true NO880760D0 (en) 1988-02-22
NO880760L NO880760L (en) 1988-02-22

Family

ID=6304389

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880760A NO880760L (en) 1986-07-02 1988-02-22 PHARMACEUTICAL PARTICULARS IMPROVEMENT.

Country Status (9)

Country Link
EP (1) EP0274498B2 (en)
JP (1) JP2569100B2 (en)
AT (1) ATE67087T1 (en)
AU (2) AU7643187A (en)
DE (2) DE3622487A1 (en)
DK (1) DK113388A (en)
FI (1) FI880839A0 (en)
NO (1) NO880760L (en)
WO (1) WO1988000046A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540714B1 (en) * 1991-05-24 1998-01-07 British Broadcasting Corporation Video image processing
DE19808634A1 (en) * 1998-02-24 1999-08-26 Schering Ag Production of pharmaceutical pellets, especially containing iloprost, with stabilized release properties
DE10318897B4 (en) * 2003-04-22 2007-04-26 Levin, Felix, Dr. Stabilized universal test formulation and test kit for protein determination in biological fluids
FR2894143B1 (en) * 2005-12-01 2008-05-02 Pierre Fabre Medicament Sa PROLONGED RELEASE COMPOSITION OF THE ACTIVE INGREDIENTS, PROCESS FOR PREPARING THE SAME AND USE THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
DD146547A5 (en) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim MEDICINAL RETARDANT SHAPE WITH UNFORGETTABLE POROESEN DIFFUSION SHELLS
DK151608C (en) * 1982-08-13 1988-06-20 Benzon As Alfred PROCEDURE FOR PREPARING A PHARMACEUTICAL PERORAL POLYDEPOT PREPARATION WITH CONTROLLED RELEASE
EP0187799A1 (en) * 1984-06-27 1986-07-23 Instrumentation Systems Limited Liquid powered cleaning apparatus

Also Published As

Publication number Publication date
FI880839A (en) 1988-02-23
AU7817891A (en) 1991-09-05
DE3772954D1 (en) 1991-10-17
JP2569100B2 (en) 1997-01-08
JPH01500992A (en) 1989-04-06
EP0274498B1 (en) 1991-09-11
EP0274498B2 (en) 1994-08-17
FI880839A0 (en) 1988-02-23
DK113388D0 (en) 1988-03-02
EP0274498A1 (en) 1988-07-20
DK113388A (en) 1988-03-02
AU7643187A (en) 1988-01-29
DE3622487A1 (en) 1988-01-14
WO1988000046A1 (en) 1988-01-14
ATE67087T1 (en) 1991-09-15
NO880760L (en) 1988-02-22

Similar Documents

Publication Publication Date Title
ATE66143T1 (en) SLOW RELEASE SOLID PREPARATION.
DE3880593T2 (en) Medicinal preparations with a delayed release of active ingredient.
SE7906119L (en) TOXIC RETARD FORM WITH INSULABLE POROSA DIFFUSION WRAP
ATE36809T1 (en) TRANSDERMAL DRUG FORM.
GR910100283A (en) Oral solid pharmaceutical form and administration therefor
DK0841903T3 (en) Oral pharmaceutical preparations containing antimicrobially active active substances and sustained release pantoprazole
DE68913979D1 (en) Medicinal preparations containing delayed release of active substances containing cation exchange resins and carboxyl-containing synthetic resins.
NO871774L (en) MEDICINE SYSTEM WITH CONTROLLED RELEASE OF THE ACTIVE AGENT.
DE3688674T2 (en) Hydroxypropyl cellulose ether-containing agents with delayed release of active ingredient.
MY101593A (en) Sustained release preparation.
ATE68969T1 (en) GRANULA REMAINING IN THE STOMACH.
DE69229949T2 (en) MEDICINAL PRODUCTS CONTAINING DILTIAZEM WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES
MY100721A (en) Therapeutic agent.
DK344586D0 (en) TIME-CONTROLLED MEDICINAL DELIVERY
NO922031D0 (en) Aqueous calcium citrate preparations AND USE OF THEM
DK0615442T3 (en) Sun-regulated gelatin-based thermocloid matrix for retarded oral release forms.
ES8105145A1 (en) Hydroxyalkyl-starch drug carrier.
NO880760L (en) PHARMACEUTICAL PARTICULARS IMPROVEMENT.
DE240257T1 (en) COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS WITH CALCIUM REGULATING ACTIVITY.
ATE84221T1 (en) MEDICATIONS CONTAINING METHYLCELLULOSE.
IT8722218A0 (en) PHTHALAZINE DERIVATIVES WITH PHARMACEUTICAL ACTIVITY.
DE68906132T2 (en) Pharmaceutical preparation containing flecainide acetate with delayed release of active ingredient.
TR199800954T2 (en) High content famciclovir tablets.
ES2186909T3 (en) ANTIPALUDIC AGENTS AND ANTIBABESIOSIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
IT8622082A0 (en) PHARMACEUTICAL PREPARATION BASED ON BUFLOMEDIL HYDROCHLORIDE, IN THE FORMS OF CONTROLLED RELEASE TABLETS AND RELATED PREPARATION PROCEDURE.